Clinical Trials Directory

Trials / Unknown

UnknownNCT01626963

Single-port Versus Conventional Laparoscopic Colorectal Surgery

Randomised-controlled Trial on the Immune Response to Single-port Access Versus Conventional Laparoscopic Colorectal Surgery

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
North Tees and Hartlepool NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Conventional multi-port laparoscopic surgery (CL) is now a standard approach to colorectal resections, due to it's short-term benefits over conventional open surgery. In recent years, several studies have demonstrated that - in suitable patients - single-port access surgery (SPA) has similar clinical outcome compared to CL, with additional cosmetic benefits. It remains, however, unclear whether the trauma of surgery is also less for SPA compared to CL. In this study, the investigators aim to randomise patients who are deemed suitable for SPA surgery to either SPA approach, or CL; in addition to clinical outcomes including length of operating time, post-operative pain scores, complications, quality of life indicators and cosmetic appearance, the investigators aim to compare the physiological response to trauma through biochemical markers (including C-reactive protein, White Blood Cell count) and cytokine expression (i.e. Interleukins IL-6 and IL-8). Patients will be analysed according to intention-to-treat analysis, with 25 patients in the SPA and 25 patients in the CL group. The patients will be operated by surgeons proficient in both CL and SPA surgery, and followed-up for the duration of their hospitalisation as well as at their routine out-patient visits, using questionnaires.

Conditions

Interventions

TypeNameDescription
PROCEDURESingle-port access surgerySurgery carried out through a single incision laparoscopic approach
PROCEDUREConventional Laparoscopic AccessSurgery through standard multiport laparoscopic approach

Timeline

Start date
2014-01-01
Primary completion
2016-07-01
Completion
2016-12-01
First posted
2012-06-25
Last updated
2016-03-24

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01626963. Inclusion in this directory is not an endorsement.